SCHEMBL13087683

SCHEMBL13087683

O=S(=O)(C1CC1)N1CCC(Oc2cc(-c3cccc(F)c3)cc3ccncc23)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 8/20 0.46
CHUK O15111 5/20 0.46
CYP17A1 P05093 2/20 0.41
CYP21A2 P08686 2/20 0.41
CYP3A4 P08684 2/20 0.39
CYP19A1 P11511 1/20 0.39
CYP11B1 P15538 1/20 0.39
NAMPT P43490 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
CSNK1E P49674 1/20 0.36
NAAA Q02083 1/20 0.35
TP53 P04637 1/20 0.35
CACNB4 O00305 1/20 0.35
CACNA1A O00555 1/20 0.35
CACNA1G O43497 1/20 0.35
CACNG3 O60359 1/20 0.35
CACNA1F O60840 1/20 0.35
CACNA1H O95180 1/20 0.35
CACNB3 P54284 1/20 0.35
CACNA2D1 P54289 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13087858 0.91 IKBKB (0.48) IKBKBCHUKCYP11B1SMN1; SMN2TDO2
SCHEMBL13087672 0.90 IKBKB (0.58) IKBKBCHUKCYP17A1CYP21A2CYP3A4
SCHEMBL13087965 0.89 IKBKB (0.54) IKBKBCHUKCYP17A1CYP21A2CYP3A4
SCHEMBL13087967 0.89 IKBKB (0.48) IKBKBCHUKNAMPTNAAACACNB4
SCHEMBL13088200 0.89 IKBKB (0.46) IKBKBCHUKCYP17A1CYP21A2CYP11B1
SCHEMBL13087958 0.88 IKBKB (0.48) IKBKBCHUKCYP19A1CYP11B1NAMPT
SCHEMBL13087957 0.87 IKBKB (0.47) IKBKBCHUKCYP17A1CYP21A2CYP3A4
SCHEMBL13088201 0.87 IKBKB (0.49) IKBKBCHUKCYP11B1NAMPTSMN1; SMN2
SCHEMBL13088204 0.86 IKBKB (0.48) IKBKBCHUKCYP17A1CYP21A2NAMPT
SCHEMBL13087830 0.86 IKBKB (0.48) IKBKBCHUKCYP17A1CYP21A2NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8299055-B2 8-substituted isoquinoline derivative and the use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2012-10-30 US disclosed
US-8299055-B2 8-substituted isoquinoline derivative and the use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2012-10-30 US disclosed
US-20100261701-A1 8-Substituted isoquinoline derivative and the use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2010-10-14 US disclosed
US-20100261701-A1 8-Substituted isoquinoline derivative and the use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2010-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100261701-A1 8-Substituted isoquinoline derivative and the use thereof RELA, NFKBIA, NFKB2 IKBKB 7/4885CHUK 17/4885CYP17A1 777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.